Douglas G Gabler

Title: Douglas G Gabler: Innovator in Bile Acid Derivatives

Introduction

Douglas G Gabler is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of bile acid derivatives. His work focuses on innovative methods to inhibit metalloproteinase enzymes, which play a crucial role in various diseases.

Latest Patents

Douglas G Gabler holds a patent for "Bile acid inhibitors of metalloproteinase enzymes." This invention relates to a bile acid derivative that is derivatized at the carboxyl group with a hydroxamic acid or hydroxamate ester. The invention also includes methods for using bile acids or their derivatives to inhibit metalloproteinase enzymes, which can be therapeutically beneficial in treating diseases associated with these enzymes. Gabler's patent is a testament to his innovative approach in addressing complex biochemical challenges. He has 1 patent to his name.

Career Highlights

Gabler is associated with Osteoarthritis Sciences, Inc., where he continues to explore the therapeutic potential of bile acid derivatives. His research has implications for treating conditions related to metalloproteinase activity, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Gabler has collaborated with esteemed colleagues such as Alan R Jacobson and Jozef Oleksyszyn. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Douglas G Gabler is a prominent figure in the realm of biochemistry, particularly known for his work on bile acid derivatives and metalloproteinase inhibitors. His contributions are paving the way for new therapeutic approaches in medicine.